vancomycin has been researched along with Benign Neoplasms in 151 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 16 (10.60) | 18.7374 |
| 1990's | 59 (39.07) | 18.2507 |
| 2000's | 23 (15.23) | 29.6817 |
| 2010's | 34 (22.52) | 24.3611 |
| 2020's | 19 (12.58) | 2.80 |
| Authors | Studies |
|---|---|
| Antypenko, OM; Berest, GG; Katsev, AM; Kovalenko, SI; Nosulenko, IS; Shandrovskaya, OS; Voskoboynik, OY | 1 |
| Franzyk, H; Frimodt-Møller, N; Jahnsen, RD; Nielsen, HM; Sandberg-Schaal, A; Vissing, KJ | 1 |
| Abdelrahman, DH; AbuSara, AK; Al-Shaer, MH; Habash, KI; Le, J; Nazer, LH | 1 |
| Amini, S; Ekhtiari Kolour, SR; Hadjibabaie, M; Kargar, M; Mohammadi, M; Sadeghi, K; Shahrami, B; Taghvaye Masoumi, H; Vaezi, M | 1 |
| Aftandilian, CC; Agyeman, PKA; Castagnola, E; Chirra, KM; Dupuis, LL; Groll, AH; Haeusler, GM; Lehrnbecher, T; Loves, R; Phillips, B; Schneider, C; Sung, L; van de Wetering, M | 1 |
| Del Rosario-García, B; García-Marrero, R; García-Rosado, D; Gómez-Sirvent, JL; González-García, J; López-Lirola, AM; Nazco-Casariego, GJ; Oramas-Rodríguez, JM | 1 |
| Avula, B; Balachandran, P; Bennett, MM; Carr, MA; Kumarihamy, M; Lovell, KM; Marquart, ME; Muhammad, I; Nanayakkara, NPD; Tripathi, S; Wang, M; Wellington, OI; Zhang, J; Zhao, J | 1 |
| Araújo, OR; Barbosa, LC; Carlesse, FAMC; Carreira, LY; Fonseca, FMCD; Lima, APC; Marques, LMA; Pignati, LT; Silva, AMPSD; Silva, DCBD; Sodré, JJM | 1 |
| Abgrall, S; Chabrol, A; Couzigou, C; de Lastours, V; de Raigniac, A; Kerneis, S; Lafaurie, M; Lepeule, R; Lescure, X; Lesprit, P; Longuet, P; Manceron, V; Montlahuc, C; Vanjak, D | 1 |
| Gupta, S; Hanna, PE; Harden, D; Katz-Agranov, N; Leaf, DE; Moreno, D; Ouyang, T; Reynolds, KL; Seethapathy, H; Sise, ME; Strohbehn, IA; Wang, Q | 1 |
| Arriaga-García, FJ; Medellín-Garibay, SE; Milán-Segovia, RDC; Pérez-González, LF; Rodríguez-Báez, AS; Romano-Moreno, S; Velarde-Salcedo, R | 1 |
| Chen, P; He, L; Li, D; Li, M; Sun, P; Wang, X; Yang, W; Zhang, C; Zhang, Y | 1 |
| Karandikar, MV; Milliren, CE; Peiris, P; Place, AE; Sandora, TJ; Sharma, T; Zaboulian, R | 1 |
| Faine, BA; Jansma, B; Negaard, B; Talan, DA; Vakkalanka, P | 1 |
| Hasegawa, H; Horino, T; Imai, M; Izumisawa, T; Kaneko, T; Saito, D; Soma, M; Takahashi, N; Wakui, N | 1 |
| Bermudez, A; Bose, RJC; Chang, E; Gambhir, SS; Garcia Marques, FJ; Habte, F; Massoud, TF; McCarthy, JR; Mylonakis, E; Natarajan, A; Paulmurugan, R; Pitteri, SJ; Robinson, E; Sukumar, UK; Tharmalingam, N; Zeng, Y | 1 |
| Abolghasemi, S; Mardani, M; Shabani, S | 1 |
| Courter, J; Dahale, D; Danziger-Isakov, L; Demmel, K; Geller, J; Goldstein, SL; Haslam, DB; O'Brien, M; Young, J | 1 |
| Almatrafi, A; Alqahtani, M; Alqahtani, S; Alsultan, A; Alzamil, F; Asiri, Y; Bin Aydan, N | 1 |
| Dong, Y; Li, Z; Wang, G; Wang, H; Zhuang, H | 1 |
| Bester, L; Govender, T; Kalhapure, RS; Mocktar, C; Oh, JK; Rambharose, S; Renukuntla, J; Sikwal, DR; Singh, S | 1 |
| Bittinger, K; Bushman, FD; Facciabene, A; Ganetsky, A; Gill, S; Guedan, S; June, CH; Morgan, MA; Pierini, S; Rafail, S; Tanes, C; Tanyi, JL; Uribe-Herranz, M | 1 |
| Babady, NE; Cohen, N; Gedrimaite, Z; Morjaria, S; Paskovaty, A; Riedel, E; Seier, K; Seo, SK; Tang, YW | 1 |
| Andre, N; Blin, O; Coze, C; Galambrun, C; Gallais, F; Guilhaumou, R; Marsot, A | 1 |
| Hirai, K; Ishii, H; Itoh, K; Kimura, M; Nakatani, E; Sugiyama, K | 1 |
| Jamal, M; Nesher, L; Prince, RA; Raad, I; Rice, SA; Rolston, KVI; Rybak, MJ | 1 |
| Hashimoto, H; Koido, K; Nakashima, T; Ohno, T; Terakado, H | 1 |
| Echizen, H; Kato, T; Nakayama, H; Suzuki, M | 1 |
| Coyle, E; Kapadia, M; Prince, RA; Rolston, KV; Tarrand, J | 1 |
| Besece, D; Lamp, KC; McConnell, SA; Rolston, KV; White, P; Yoon, M | 1 |
| Antonio, M; Ardanuy, C; Arnan, M; Ayats, J; Bodro, M; Camoez, M; Carratalà, J; Domínguez, MÁ; García-Vidal, C; Gudiol, C; Obed, M | 1 |
| Bijleveld, YA; Kemper, EM; Mathôt, RA; Pajkrt, D; Sanders, SJ; Sinkeler, F; van de Wetering, M; van Eijkelenburg, NK | 1 |
| Coyle, E; Nesher, L; Prince, RA; Rolston, K; Shelburne, S; Wang, W | 1 |
| Calvo-García, N; de Frutos-Serna, M; García-Sánchez, JE; Hernández-Egido, S; María-Blázquez, A; Siller-Ruiz, M | 1 |
| Ahmad, S; Allen, SL; Kabir, R; Patel, K | 1 |
| Abdel Hadi, O; Al Omar, S; Le, J; Mubarak, S; Nazer, LH | 1 |
| Anguita, P; Cobo Reinoso, J; Gani, R; Grau Cerrato, S; Mensa Pueyo, J; Rubio-Rodríguez, D; Rubio-Terrés, C; Salavert Lletí, M; Toledo, A; Watt, M | 1 |
| Araujo, OR; Arduini, RG; Petrilli, AS; Seixas, GT; Silva, DC | 1 |
| Nesher, L; Prince, RA; Rolston, KV; Shelburne, SA; Wang, W | 1 |
| Akhtar, N; Nizamuddin, S; Sultan, F; Zafar, W | 1 |
| Al-Nahedh, M; Knoebel, RW; Parsad, S; Pettit, NN; Pisano, J; Vicente, M | 1 |
| André, N; Boulamery, A; Coze, C; Dupouey, J; Galambrun, C; Guilhaumou, R; Marsot, A; Simon, N | 1 |
| Chemaly, RF; Nesher, L; Rolston, KV; Tarrand, J | 1 |
| Nesher, L; Prince, RA; Rolston, KV; Rybak, MJ; Smith, JR; Wang, W | 1 |
| Dinh, A; Le Monnier, A; Tilleul, P; Watt, M | 1 |
| Penel, N; Yazdanpanah, Y | 1 |
| Hashida, T; Inui, K; Katsura, T; Masuda, S; Omote, S; Yano, I; Yano, Y | 1 |
| El-Al, AK; El-Mahallawy, HA; El-Wakil, M; Loutfy, SA; Morcos, H | 1 |
| Al-Kofide, H; Al-Naim, L; Zaghloul, I | 1 |
| Sadoh, S; Tsuji, Y; Tsukamoto, K | 1 |
| Bell, LM; Coffin, SE; Gross, R; Localio, AR; Prasad, PA; Walsh, TJ; Zaoutis, TE | 1 |
| Aoyama, T; Hayashi, H; Iida, H; Matsumoto, Y; Shimazaki, N; Umeda, K | 1 |
| Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM | 1 |
| Watanabe, K | 1 |
| He, WJ; Tan, NH; Xu, HM; Xu, WY; Zeng, GZ; Zhao, SM | 1 |
| Cornely, OA; Fätkenheuer, G; Hallek, M; Liss, BJ; Seifert, H; Vehreschild, JJ; Vehreschild, MJ; Wisplinghoff, H | 1 |
| Adachi, JA; Chemaly, RF; Hachem, R; Mahajan, SN; Mulanovich, V; Raad, II; Rolston, KV; Shah, JN; Tverdek, F | 1 |
| Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A | 1 |
| Akan, H; Calandra, T; Cometta, A; Crokaert, F; De Bock, R; Engelhard, D; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Korten, V; Marchetti, O; Padmos, A; Paesmans, M; Skoutelis, A; Vandenbergh, M; Vandercam, M; Viscoli, C; Zinner, S | 1 |
| Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Glasmacher, A; Wade, JC | 1 |
| Billheimer, D; Calder, C; Frangoul, H; Manes, B; Tsiatis, AC; Wilkerson, KS | 1 |
| Berger, C; Kindli, K; Nadal, D; Niggli, FK | 1 |
| Castellano, A; De Sio, L; Donfrancesco, A; Fidani, P; Gareri, R; Ilari, I; Jenkner, A; Milano, GM | 1 |
| Aguado, JM; Colomer, R; Cortés-Funes, H; López-Martín, A; López-Medrano, F; Lumbreras, C; Rodríguez, FJ; Sánchez-Muñoz, A | 1 |
| Caron, HN; Kremer, LC; van de Wetering, MD; van Woensel, JB | 1 |
| Hartman, CS; Jaksic, B; Leonard, LB; Martinelli, G; Perez-Oteyza, J; Tack, KJ | 1 |
| Rolston, KV; Safdar, A | 1 |
| Mortlock, S | 1 |
| Matar, MJ; Rolston, KV; Safdar, A | 1 |
| Matar, MJ; Raad, I; Rolston, KV; Tarrand, J | 1 |
| Abdullah, WA; Ai, CL; Ariffin, H; Lee, CL | 1 |
| Henry, SA | 1 |
| Bodey, GP; Bolivar, R; Fainstein, V; Hay, M; Jadeja, L; Keating, M; McCredie, K | 1 |
| Hurse, A; McDonald, M; Sim, KN | 1 |
| Klastersky, J; Malarme, M; Meunier-Carpentier, F | 1 |
| Abs, L; Bekradda, M; Culine, S; Droz, JP; Farhat, F; Kattan, J | 1 |
| Dova, H; Efremidis, AP; Hajichristou, H; Koumakis, G; Plataniotis, G; Skouteri, H; Vassilomanolakis, M | 1 |
| Barker, GJ; Call, SK; Gamis, AS | 1 |
| Ane, M; Claeyssens, S; Fedacou, F; Guitard, J; Izard, P; Juricic, M; Krimou, A; Lemozy, J; Prere, MF; Rubie, H | 1 |
| Freifeld, AG; Gill, V; Gress, J; Hathorn, J; Jarosinski, P; Marshall, D; Rubin, M; Steinberg, SM; Walsh, T; Young, RC | 1 |
| Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P | 1 |
| Chang, D; Liem, L; Malogolowkin, M | 1 |
| Borja, J; García-Barbal, J; Gratacós, L | 1 |
| Artiges, V; Bouffet, E; Bouhour, D; Brunat Mentigny, M; Charra, C; Couillioud, D; Frappaz, D; Fuhrmann, C | 1 |
| Bourcier, JD; Cripps, MC; Evans, WK; Goel, R; Huan, SD; Perrault, DJ; Prosser, IA; Soltys, KM; Tomiak, AT; Yau, JC | 1 |
| Amos, G; Bodey, GP; Elting, L; Fainstein, V; Nguyen, H; Rolston, KV | 1 |
| Klastersky, J | 1 |
| Broun, ER; Hromas, RA; Kneebone, PH; Sundblad, K; Tricot, G; Wheat, JL | 1 |
| Bustamante, CI | 1 |
| Henwick, S; Koehler, M; Patrick, CC | 1 |
| Dauriac, C; Donio, PY; Grulois, I; Lamy, T; Le Prisé, PY; Michelet, C | 1 |
| Amaral, D; Babin-Boilletot, A; Clavert, JM; Geiss, S; Maloisel, F | 1 |
| Freifeld, AG | 1 |
| Andremont, A; Caillon, J; Flahault, A; Hill, C; Marty, L; Suarez, B | 1 |
| Chang, D | 1 |
| Abi-Said, D; Bodey, GP; Ghaddar, HM; Hachem, RY; Karl, CL; Pandya, RG; Raad, II; Rolston, KV; Whimbey, EE | 1 |
| Daghistani, D; Horn, M; Rodriguez, Z; Schoenike, S; Toledano, S | 1 |
| Cimino, M; Gucalp, R; Oblon, D; Ramphal, R; Rotstein, C | 1 |
| Carraher, M; Chung, M; de Lencastre, H; Gedris, C; Montecalvo, MA; VanHorn, K; Wormser, GP | 1 |
| Schreiber, J; Shurin, SB | 1 |
| Jenson, HB | 1 |
| Drgona, L; Krcmery, V; Kukuckova, E; Lacka, J; Oravcova, E; Trupl, J | 1 |
| Halko, J; Kremery, V; Netriova, D; Studena, M | 1 |
| Avalos, B; Biggs, J; Brodsky, I; Copelan, E; Crilley, P; Downs, K; Marks, DI; Moul, J; Penza, S; Sabol, P; Styler, MJ; Szer, J; Topolsky, D | 1 |
| De Pauw, BE; Deresinski, SC; Dompeling, EC; Donnelly, JP; Feld, R; Lane-Allman, EF | 1 |
| Dholakia, N; Dvorak, T; Ho, DH; LeBlanc, B; Rolston, KV; Streeter, H | 1 |
| Abi-Said, D; Bodey, G; Raad, I; Rolston, K; Whimbey, E | 1 |
| Armstrong, D; Boone, N; Brown, A; Chung, M; Delencastre, H; Eagan, J; Henning, KJ; Wollner, N | 1 |
| Concia, E; Cruciani, M; Lazzarini, L; Malena, M; Messori, A; Rampazzo, R; Todeschini, G | 1 |
| Barriga, FJ; Becker, A; Capdeville, V; Martinez, A; Potin, M; Rojo, H; Sapunar, F; Varas, M; Vial, PA | 1 |
| Garcia, R; Raad, I | 1 |
| Demitrovicová, A; Grausová, S; Hal'ko, J; Kral'ovicová, K; Krcméry, V; Krupová, I; Kukucková, E; Netriová, J; Stopková, K; Studená-Mrázová, M; Trupl, J | 1 |
| Botek, R; Grausova, S; Grey, E; Koren, P; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Lacka, J; Oravcova, E; Rusnakova, V; Sorkovska, D; Spanik, S; Stopkova, K; Studena, M; Svec, J; Trupl, J | 1 |
| Baciuchka, M; Bagarry-Liegey, D; Braguer, D; Carissimi, P; Carle, G; Cohen, P; Crevat, A; Delorme, J; Duffaud, F; Favre, R; Guillet, P; La Scola, B; Lorvellec, K; Martin, N; Nicoara, A; Quilichini, F | 1 |
| Morris, JG; Qaiyumi, S; Roghmann, MC; Schwalbe, R | 1 |
| Casali, A; Della Giulia, M; Di Lauro, L; Gionfra, T; Santini, S; Sega, FM; Vici, P | 1 |
| Warnick, F | 1 |
| Demitrovicova, A; Grausova, S; Halko, J; Koren, P; Kralovicová, K; Krcmery, V; Krupova, I; Kukuckova, E; Netriova, J; Novotny, J; Spanik, S; Studena-Mrazova, M | 1 |
| Andersen, J; Cassileth, PA; Fernandez, H; Goodman, M; Hanlon, J; Koya, R; Smith, R; Spector, N | 1 |
| Bodey, GP; Elting, LS; Fangtang, J; Kurtin, D; Manzullo, E; Martin, CG; Raad, II; Rolston, KV; Rubenstein, EB; Whimbey, EE | 1 |
| Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A | 1 |
| Ayats, J; Carratalà, J; Domínguez, MA; Fernández de Sevilla, A; Gudiol, F; Liñares, J; Marron, A | 1 |
| Armstrong, D; Brown, AE; Chung, M; de Lencastre, H; Tomasz, A | 1 |
| Feld, R | 1 |
| Aldaz, A; Brugarolas, A; Giráldez, J; Idoate, A; Ortega, A | 1 |
| Bibashi, E; Gompakis, N; Koliouskas, D; Roilides, E; Sidi, V; Tsakiri, A | 1 |
| Baker, R | 1 |
| Hachem, R; Hanna, H; Husni, R; Raad, I | 1 |
| Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L | 1 |
| Braine, HG; Pearson, TA; Rathbun, HK | 1 |
| Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P | 1 |
| Andremont, A; Azab, M; Boutan-Laroze, A; Droz, JP; Kattan, J; Ribrag, V | 1 |
| Riikonen, P | 1 |
| Bodnárová, J; Fuchsberger, P; Gocár, M; Koza, I; Krcméry, V; Salát, T; Sobota, R; Svec, J | 1 |
| Aoun, M; Meunier, F; Van der Auwera, P | 1 |
| Jackson, A; Kamthan, AG; Oppenheim, BA; Ranson, MR; Scarffe, JH | 1 |
| Messer, M; Nguyen, H; Rolston, KV | 1 |
| Shenep, JL | 1 |
| Bodey, GP; Ho, DH; Rolston, K | 1 |
| Berkey, P; Bodey, GP; Hayat, S; Khardori, N; Rosenbaum, B | 1 |
| Pizzo, PA; Rubin, M | 1 |
| Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW | 1 |
| Hathorn, JW; Pizzo, PA; Rubin, M | 1 |
| Anaissie, EJ; Bodey, GP; Cabanillas, F; Elting, L; Fainstein, V; Kantarjian, H; McCredie, KB; Rolston, K | 1 |
| Granowetter, L; Lange, BJ; Wells, H | 1 |
| Gress, J; Hathorn, JW; Marshall, D; Pizzo, PA; Rubin, M; Steinberg, SM | 1 |
| Cimino, MA; Emrich, LJ; Rotstein, C; Slaughter, RL | 1 |
| Bodey, GP; Ho, DH; LeBlanc, B; Rolston, KV | 1 |
| Carter, JM; Dady, PJ; Humble, MW; Lunt, H | 1 |
13 review(s) available for vancomycin and Benign Neoplasms
| Article | Year |
|---|---|
Prevalence, predictors, and mortality of bloodstream infections due to methicillin-resistant Staphylococcus aureus in patients with malignancy: systemic review and meta-analysis.
Topics: Adult; Africa; Americas; Anti-Bacterial Agents; Asia, Southeastern; Bacteremia; Child; Comorbidity; Cross Infection; Europe; Female; Humans; Male; Mediterranean Region; Methicillin-Resistant Staphylococcus aureus; Neoplasms; Observational Studies as Topic; Prevalence; Risk Factors; Staphylococcal Infections; Vancomycin | 2021 |
[Fever in patients with cancer].
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Carbapenems; Diagnosis, Differential; Drug Therapy, Combination; Fever; Humans; Naproxen; Neoplasms; Neutropenia; Opportunistic Infections; Vancomycin | 2009 |
[Progress in the study of some important natural bioactive cyclopeptides].
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Cyclosporine; Daptomycin; Depsipeptides; Gramicidin; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Molecular Structure; Neoplasms; Peptides, Cyclic; Quantitative Structure-Activity Relationship; Vancomycin | 2012 |
Prophylactic antibiotics for preventing early Gram-positive central venous catheter infections in oncology patients, a Cochrane systematic review.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Anticoagulants; Antineoplastic Agents; Catheterization, Central Venous; Drug Therapy, Combination; Gram-Positive Bacterial Infections; Heparin; Humans; Neoplasms; Odds Ratio; Randomized Controlled Trials as Topic; Teicoplanin; Vancomycin | 2005 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Colistin; Drug Combinations; Environment, Controlled; Gentamicins; Humans; Leukemia; Neoplasms; Nystatin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Methicillin-resistant Staphylococcus aureus bacteraemia.
Topics: Catheterization; Cross Infection; Humans; Methicillin; Middle Aged; Neoplasms; Penicillin Resistance; Pneumonia; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 1981 |
Febrile neutropenia.
Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases | 1993 |
Initial empiric therapy for fever in neutropenia.
Topics: Anti-Bacterial Agents; Bacteremia; Fever; Humans; Neoplasms; Neutropenia; Risk; Vancomycin | 1993 |
Complications of bacteremia due to Stomatococcus mucilaginosus in neutropenic children.
Topics: Adolescent; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Meningitis, Bacterial; Micrococcaceae; Neoplasms; Neutropenia; Pneumonia; Respiratory Distress Syndrome; Shock, Septic; Skin Diseases; Vancomycin | 1993 |
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin | 1993 |
Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Drug Therapy, Combination; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Macrolides; Neoplasms; Neutropenia; Penicillins; Vancomycin | 1996 |
Vancomycin as part of initial empirical antibiotic therapy for febrile neutropenia in patients with cancer: pros and cons.
Topics: Anti-Bacterial Agents; Fever; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Prognosis; Randomized Controlled Trials as Topic; Treatment Outcome; Vancomycin | 1999 |
Controversies in the management of febrile neutropenic cancer patients.
Topics: Agranulocytosis; Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Fever; Humans; Infection Control; Infections; Lactams; Neoplasms; Neutropenia; Pneumonia; Quinolines; Vancomycin | 1988 |
36 trial(s) available for vancomycin and Benign Neoplasms
| Article | Year |
|---|---|
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Double-Blind Method; Fever; Humans; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome; Vancomycin | 2003 |
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin | 2003 |
Vancomycin does not benefit persistently febrile neutropenic people with cancer.
Topics: Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Evidence-Based Medicine; Female; Fever; Follow-Up Studies; Humans; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Probability; Proportional Hazards Models; Reference Values; Risk Assessment; Severity of Illness Index; Tazobactam; Treatment Outcome; Vancomycin | 2004 |
Antibiotic lock with vancomycin and urokinase can successfully treat colonized central venous catheters in pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Equipment Contamination; Female; Humans; Infant; Male; Neoplasms; Urokinase-Type Plasminogen Activator; Vancomycin | 2004 |
Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Double-Blind Method; Female; Fever; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Middle Aged; Neoplasms; Neutropenia; Oxazolidinones; Vancomycin | 2006 |
Cefepime monotherapy for treatment of febrile neutropenia in children.
Topics: Adolescent; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infant; Malaysia; Male; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 2006 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients.
Topics: Acute Disease; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Colistin; Drug Combinations; Environment, Controlled; Gentamicins; Humans; Leukemia; Neoplasms; Nystatin; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1984 |
Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clinical Trials as Topic; Drug Combinations; Drug Therapy, Combination; Feces; Gentamicins; Humans; Neoplasms; Neutropenia; Pilot Projects; Random Allocation; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1981 |
Central venous catheter-related infections after bone marrow transplantation in patients with malignancies: a prospective study with short-course vancomycin prophylaxis.
Topics: Bacteremia; Bone Marrow Transplantation; Catheterization, Central Venous; Gram-Positive Bacterial Infections; Humans; Neoplasms; Prospective Studies; Vancomycin | 1995 |
Oral care with vancomycin paste for reduction in incidence of alpha-hemolytic streptococcal sepsis.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cohort Studies; Humans; Incidence; Infant; Leukemia, Myeloid, Acute; Mouth Diseases; Neoplasms; Neutropenia; Ointments; Oral Hygiene; Retrospective Studies; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1995 |
Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem.
Topics: Acyclovir; Adolescent; Adult; Aged; Bacterial Infections; Cause of Death; Ceftazidime; Child; Child, Preschool; Female; Fever; Fever of Unknown Origin; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin | 1994 |
Once daily antibiotic regimen in paediatric oncology.
Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Humans; Infant; Neoplasms; Teicoplanin; Vancomycin | 1994 |
A randomized double-blind trial of vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Topics: Adult; Aged; Double-Blind Method; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Randomized trial of the addition of gram-positive prophylaxis to standard antimicrobial prophylaxis for patients undergoing autologous bone marrow transplantation.
Topics: Acyclovir; Adult; Bacteremia; Bone Marrow Transplantation; Female; Fever; Fluconazole; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Norfloxacin; Penicillins; Premedication; Streptococcal Infections; Vancomycin | 1994 |
Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Treatment Outcome; Vancomycin | 1993 |
A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Leukocyte Count; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Neutrophils; Prospective Studies; Vancomycin | 1996 |
Prevention of indwelling central venous catheter sepsis.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Heparin; Humans; Incidence; Infant; Infection Control; Inservice Training; Male; Medical Staff, Hospital; Neoplasms; Nursing Staff, Hospital; Prospective Studies; Retrospective Studies; Sodium Chloride; Staphylococcal Infections; Vancomycin | 1996 |
Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Gentamicins; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillins; Piperacillin; Prospective Studies; Superinfection; Vancomycin | 1996 |
Early identification of neutropenic patients at risk of grampositive bacteraemia and the impact of empirical administration of vancomycin.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Skin Diseases, Bacterial; Soft Tissue Infections; Treatment Outcome; Vancomycin | 1996 |
Imipenem or cefoperazone-sulbactam combined with vancomycin for therapy of presumed or proven infection in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefoperazone; Drug Therapy, Combination; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam; Vancomycin | 1996 |
Efficacy of a vancomycin solution to prevent bacteremia associated with an indwelling central venous catheter in neutropenic and non-neutropenic cancer patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Female; Heparin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1997 |
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Drug Therapy, Combination; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Imipenem; Mycoplasma Infections; Neoplasms; Neutropenia; Pefloxacin; Thienamycins; Vancomycin | 1997 |
Do vancomycin serum levels predict failures of vancomycin therapy or nephrotoxicity in cancer patients?
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Kidney Diseases; Neoplasms; Neutropenia; Risk Factors; Slovakia; Vancomycin | 1997 |
Comparison of efficacy and safety of teicoplanin and vancomycin in children with antineoplastic therapy-associated febrile neutropenia and gram-positive bacteremia.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bacteremia; Child; Child, Preschool; Female; Gram-Positive Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia; Staphylococcus aureus; Streptococcus; Teicoplanin; Vancomycin | 2000 |
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin | 2002 |
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin | 1992 |
Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Kidney; Kidney Diseases; Male; Middle Aged; Neoplasms; Neutropenia; Pefloxacin; Piperacillin; Vancomycin | 1992 |
Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
Topics: Adolescent; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Vancomycin | 1991 |
Randomized study of vancomycin versus teicoplanin for the treatment of gram-positive bacterial infections in immunocompromised hosts.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Glycopeptides; Gram-Positive Bacteria; Humans; Middle Aged; Neoplasms; Prospective Studies; Teicoplanin; Vancomycin | 1991 |
Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients.
Topics: Adolescent; Adult; Aged; Catheterization, Central Venous; Double-Blind Method; Female; Humans; Immune Tolerance; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Premedication; Randomized Controlled Trials as Topic; Sepsis; Vancomycin | 1990 |
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin | 1991 |
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer.
Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin | 1988 |
Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
Topics: Adult; Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Piperacillin; Prospective Studies; Random Allocation; Vancomycin | 1988 |
Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Carbenicillin; Ceftazidime; Cephalothin; Child; Child, Preschool; Drug Therapy, Combination; Fever; Gentamicins; Humans; Infant; Neoplasms; Neutropenia; Random Allocation; Vancomycin | 1988 |
103 other study(ies) available for vancomycin and Benign Neoplasms
| Article | Year |
|---|---|
Synthesis and biological activity of novel N-cycloalkyl-(cycloalkylaryl)-2-[(3-R-2-oxo-2H-[1,2,4]triazino[2,3-c]quinazoline-6-yl)thio]acetamides.
Topics: Acetamides; Anti-Bacterial Agents; Antineoplastic Agents; Bacteria; Bacterial Infections; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Microbial Sensitivity Tests; Neoplasms; Quinazolines | 2011 |
Tailoring cytotoxicity of antimicrobial peptidomimetics with high activity against multidrug-resistant Escherichia coli.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Antineoplastic Agents; Cell Proliferation; Circular Dichroism; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Liposomes; Microbial Sensitivity Tests; Molecular Structure; Neoplasms; Peptidomimetics; Structure-Activity Relationship; Tumor Cells, Cultured | 2014 |
Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Bayes Theorem; Cohort Studies; Critical Illness; Drug Monitoring; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin | 2022 |
Adherence to practice guidelines for the management of febrile neutropenia in patients undergoing hematopoietic stem cell transplantation: An observational study in a referral center in Iran.
Topics: Anti-Bacterial Agents; Febrile Neutropenia; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Iran; Neoplasms; Referral and Consultation; Vancomycin | 2023 |
Clostridioides difficile infection in paediatric patients with cancer and haematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Child; Clostridioides difficile; Clostridium Infections; Hematopoietic Stem Cell Transplantation; Humans; Metronidazole; Neoplasms; Recurrence; Retrospective Studies; Vancomycin | 2022 |
Vancomycin versus daptomycin for the treatment of confirmed gram-positive catheter-related bloodstream infections in oncology patients.
Topics: Anti-Bacterial Agents; Bacteremia; Catheters; Daptomycin; Humans; Medical Oncology; Neoplasms; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2022 |
Synthesis and Inhibitory Activity of Machaeridiol-Based Novel Anti-MRSA and Anti-VRE Compounds and Their Profiling for Cancer-Related Signaling Pathways.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biological Products; Luciferases; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Monoterpenes; Neoplasms; Resveratrol; Signal Transduction; Transcription Factors; Vancomycin | 2022 |
A case-control study of Clostridioides difficile symptomatic infections in a pediatric cancer hospital.
Topics: Anti-Bacterial Agents; Asparaginase; Busulfan; Cancer Care Facilities; Carboplatin; Case-Control Studies; Cefepime; Child; Clostridioides difficile; Clostridium Infections; Cross Infection; Humans; Melphalan; Meropenem; Neoplasms; Retrospective Studies; Risk Factors; Vancomycin | 2023 |
Efficacy of vancomycin lock therapy for totally implantable venous access port-related infection due to coagulase-negative staphylococci in 100 patients with cancer.
Topics: Adult; Anti-Bacterial Agents; Catheter-Related Infections; Catheterization, Central Venous; Catheters, Indwelling; Coagulase; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Staphylococcus; Vancomycin | 2023 |
Medication-Related Adverse Events and Discordancies in Cystatin C-Based vs Serum Creatinine-Based Estimated Glomerular Filtration Rate in Patients With Cancer.
Topics: Adult; Aged; Baclofen; Cohort Studies; Creatinine; Cystatin C; Digoxin; Glomerular Filtration Rate; Humans; Hyperkalemia; Male; Neoplasms; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2023 |
Model-informed precision dosing of antimicrobial drugs in pediatrics: experiences from a pilot scale program.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Clindamycin; Critical Illness; Fluconazole; Humans; Linezolid; Meropenem; Metronidazole; Neoplasms; Piperacillin; Vancomycin | 2023 |
Near infrared II excitation nanoplatform for photothermal/chemodynamic/antibiotic synergistic therapy combating bacterial biofilm infections.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biofilms; Cell Line, Tumor; Humans; Hydrogen Peroxide; Nanoparticles; Neoplasms; Photothermal Therapy; Tumor Microenvironment; Vancomycin | 2023 |
Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus Incidence.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Child; Child, Preschool; Febrile Neutropenia; Female; Humans; Male; Neoplasms; Retrospective Studies; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2020 |
Guideline adherence for the management of emergency department patients with febrile neutropenia and no infection source: Is there room for improvement?
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Cohort Studies; Emergency Service, Hospital; Febrile Neutropenia; Female; Guideline Adherence; Hospitalization; Humans; Male; Middle Aged; Neoplasms; Patient Discharge; Retrospective Studies; Risk Factors; Tertiary Care Centers; Vancomycin | 2020 |
Increased Vancomycin Clearance in Patients with Solid Malignancies.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin | 2020 |
Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.
Topics: Animals; Anti-Bacterial Agents; Extracellular Vesicles; Macrophages; Mice; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2020 |
Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Clostridium Infections; Comorbidity; Drug Resistance, Bacterial; Female; Humans; Immunocompromised Host; Iran; Male; Meropenem; Middle Aged; Neoplasms; Prevalence; Program Evaluation; Vancomycin; Young Adult | 2020 |
Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications.
Topics: Acute Kidney Injury; Adolescent; Cefepime; Child; Child, Preschool; Databases, Factual; Febrile Neutropenia; Female; Humans; Infant; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin | 2020 |
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling.
Topics: Anti-Bacterial Agents; Area Under Curve; Cohort Studies; Female; Gram-Positive Bacterial Infections; Humans; Infusions, Intravenous; Male; Middle Aged; Models, Theoretical; Neoplasms; Predictive Value of Tests; Retrospective Studies; Vancomycin | 2020 |
Enhancing targeted antibiotic therapy via pH responsive solid lipid nanoparticles from an acid cleavable lipid.
Topics: Animals; Anti-Bacterial Agents; Cell Survival; Drug Carriers; Humans; Hydrogen-Ion Concentration; Inflammation; Lipids; Methicillin-Resistant Staphylococcus aureus; Mice; Mice, Inbred BALB C; Nanoparticles; Neoplasms; Skin; Staphylococcal Infections; Tumor Cells, Cultured; Vancomycin | 2017 |
Gut microbiota modulates adoptive cell therapy via CD8α dendritic cells and IL-12.
Topics: Adult; Aged; Animals; Bacteria; CD8 Antigens; Cell Line, Tumor; Cohort Studies; Dendritic Cells; Disease Models, Animal; Fecal Microbiota Transplantation; Female; Gastrointestinal Microbiome; Hematopoietic Stem Cell Transplantation; Host Microbial Interactions; Humans; Immunotherapy, Adoptive; Interleukin-12; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Neomycin; Neoplasms; T-Lymphocytes; Treatment Outcome; Vancomycin | 2018 |
Impact of QuickFISH in addition to antimicrobial stewardship on vancomycin use and resource utilization in cancer patients with coagulase-negative staphylococcal blood cultures.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Bacteremia; Bacteriological Techniques; Blood Culture; Clinical Laboratory Techniques; Coagulase; Female; Humans; In Situ Hybridization, Fluorescence; Male; Middle Aged; Neoplasms; Staphylococcal Infections; Staphylococcus; Vancomycin; Young Adult | 2018 |
Vancomycin in Pediatric Patients with Solid or Hematological Malignant Disease: Predictive Performance of a Population Pharmacokinetic Model and New Optimized Dosing Regimens.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Child, Preschool; Drug Dosage Calculations; Drug Monitoring; Emollients; Female; Hematologic Neoplasms; Humans; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin | 2018 |
Validation of a Nomogram for Achieving Target Trough Concentration of Vancomycin: Accuracy in Patients With Augmented Renal Function.
Topics: Age Factors; Aged; Aged, 80 and over; Anti-Bacterial Agents; Brain Injuries; Drug Monitoring; Febrile Neutropenia; Female; Glomerular Filtration Rate; Humans; Male; Middle Aged; Neoplasms; Nomograms; Retrospective Studies; Vancomycin | 2018 |
Bactericidal activity of ceftaroline, vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus isolates from cancer patients.
Topics: Anti-Bacterial Agents; Bacterial Infections; Ceftaroline; Cephalosporins; Daptomycin; Humans; Methicillin; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2019 |
Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Drug Monitoring; Female; Humans; Japan; Male; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin | 2020 |
Vancomycin Pharmacokinetics in Patients with Advanced Cancer Near End of Life.
Topics: Adult; Aged; Anti-Bacterial Agents; Bayes Theorem; Drug Monitoring; Female; Glomerular Filtration Rate; Humans; Kidney; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Terminal Care; Vancomycin | 2019 |
Spectrum of gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients.
Topics: Acetamides; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Child; Child, Preschool; Daptomycin; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Neoplasms; Oxazolidinones; Prevalence; Vancomycin; Young Adult | 2013 |
Daptomycin use in neutropenic patients with documented gram-positive infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Daptomycin; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Vancomycin | 2014 |
Increase in bloodstream infection due to vancomycin-susceptible Enterococcus faecium in cancer patients: risk factors, molecular epidemiology and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Bacteremia; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Incidence; Male; Middle Aged; Multilocus Sequence Typing; Neoplasms; Patient Outcome Assessment; Prospective Studies; Risk Factors; Vancomycin; Young Adult | 2013 |
Clinical evaluation of vancomycin dosage in pediatric oncology patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Female; Humans; Infant; Male; Neoplasms; Retrospective Studies; Serum; Vancomycin | 2014 |
In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients.
Topics: Acetamides; Aminoglycosides; Anti-Bacterial Agents; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Lipoglycopeptides; Microbial Sensitivity Tests; Neoplasms; Oxazolidinones; Vancomycin | 2014 |
[Epidemiology of Clostridium difficile-associated disease (CDAD) in Salamanca].
Topics: Aged; Aged, 80 and over; Antacids; Anti-Bacterial Agents; Antineoplastic Agents; Clostridioides difficile; Clostridium Infections; Comorbidity; Cross Infection; Diarrhea; Enterocolitis, Pseudomembranous; Female; Hospitals, University; Humans; Incidence; Male; Metronidazole; Middle Aged; Neoplasms; Postoperative Complications; Recurrence; Spain; Surveys and Questionnaires; Vancomycin | 2014 |
Assessing outcomes of adult oncology patients treated with linezolid versus daptomycin for bacteremia due to vancomycin-resistant Enterococcus.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Daptomycin; Enterococcus; Female; Humans; Linezolid; Male; Middle Aged; Neoplasms; Retrospective Studies; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2016 |
Vancomycin pharmacokinetics and predicted dosage requirements in pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Drug Dosage Calculations; Female; Forecasting; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2016 |
Economic assessment of fidaxomicin for the treatment of Clostridium difficile infection (CDI) in special populations (patients with cancer, concomitant antibiotic treatment or renal impairment) in Spain.
Topics: Aminoglycosides; Anti-Bacterial Agents; Clostridioides difficile; Clostridium Infections; Cost-Benefit Analysis; Diarrhea; Fidaxomicin; Humans; Kidney Diseases; Neoplasms; Quality-Adjusted Life Years; Spain; Treatment Outcome; Vancomycin | 2015 |
Vancomycin Therapeutic Targets and Nephrotoxicity in Critically Ill Children With Cancer.
Topics: Adolescent; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Child; Child, Preschool; Critical Illness; Female; Humans; Infant; Kidney; Male; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Vancomycin | 2016 |
In vitro activity of dalbavancin and five comparator agents against common and uncommon Gram-positive organisms isolated from cancer patients.
Topics: Anti-Bacterial Agents; Daptomycin; Gram-Positive Bacteria; Humans; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Neoplasms; Teicoplanin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2016 |
Risk factors and clinical outcomes for vancomycin-resistant enterococcus bacteraemia in hospitalised cancer patients in Pakistan: A case-control study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Case-Control Studies; Child; Data Interpretation, Statistical; Enterococcus; Female; Gram-Positive Bacterial Infections; Humans; Length of Stay; Male; Microbial Sensitivity Tests; Neoplasms; Pakistan; Risk Factors; Vancomycin; Vancomycin Resistance | 2016 |
Impact of a clinical pathway on appropriate empiric vancomycin use in cancer patients with febrile neutropenia.
Topics: Adult; Aged; Anti-Bacterial Agents; Critical Pathways; Empirical Research; Febrile Neutropenia; Female; Humans; Male; Middle Aged; Neoplasms; Practice Guidelines as Topic; Retrospective Studies; Vancomycin | 2017 |
Pediatric Patients With Solid or Hematological Tumor Disease: Vancomycin Population Pharmacokinetics and Dosage Optimization.
Topics: Anti-Bacterial Agents; Child; Cyclosporine; Drug Dosage Calculations; Drug Monitoring; Drug Therapy, Combination; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infusions, Intravenous; Male; Models, Biological; Neoplasms; Retrospective Studies; Vancomycin | 2016 |
Staphylococcus lugdunensis infections, filling in the gaps: a 3-year retrospective review from a comprehensive cancer center.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Child, Preschool; Female; Humans; Male; Middle Aged; Neoplasms; Retrospective Studies; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus lugdunensis; Vancomycin; Young Adult | 2017 |
Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients.
Topics: Aminoglycosides; Anti-Bacterial Agents; Humans; Lipoglycopeptides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Time Factors; Vancomycin | 2017 |
Cost-effectiveness analysis on the use of fidaxomicin and vancomycin to treat Clostridium difficile infection in France.
Topics: Age Factors; Aminoglycosides; Anti-Bacterial Agents; Clostridium Infections; Cost-Benefit Analysis; Drug Costs; Fidaxomicin; France; Hospitalization; Humans; Markov Chains; Models, Economic; Neoplasms; Randomized Controlled Trials as Topic; Recurrence; Renal Insufficiency; Severity of Illness Index; Vancomycin | 2017 |
Vancomycin flush as antibiotic prophylaxis for early catheter-related infections: a cost-effectiveness analysis.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Catheter-Related Infections; Cost-Benefit Analysis; Decision Support Techniques; Humans; Monte Carlo Method; Neoplasms; Risk Factors; Treatment Outcome; Vancomycin | 2009 |
A retrospective analysis of vancomycin pharmacokinetics in Japanese cancer and non-cancer patients based on routine trough monitoring data.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Asian People; Aspartate Aminotransferases; Bayes Theorem; Blood Urea Nitrogen; Creatine; Dose-Response Relationship, Drug; Drug Monitoring; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Serum Albumin; Vancomycin; Young Adult | 2009 |
Clinical implications of icaA and icaD genes in coagulase negative staphylococci and Staphylococcus aureus bacteremia in febrile neutropenic pediatric cancer patients.
Topics: Adolescent; Anti-Bacterial Agents; Bacteremia; Biofilms; Cell Adhesion Molecules; Child; Coagulase; Congo Red; Female; Fever; Genes, Bacterial; Humans; Male; Neoplasms; Neutropenia; Polymerase Chain Reaction; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2009 |
Pharmacokinetics of vancomycin in adult cancer patients.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Body Mass Index; Drug Monitoring; Female; Gram-Positive Bacterial Infections; Half-Life; Humans; Leukemia; Male; Medical Records; Metabolic Clearance Rate; Middle Aged; Neoplasms; Retrospective Studies; Vancomycin; Young Adult | 2010 |
[Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Monitoring; Female; Half-Life; Humans; Male; Neoplasms; Staphylococcal Infections; Vancomycin | 2010 |
Risk factors and predictors for candidemia in pediatric intensive care unit patients: implications for prevention.
Topics: Anti-Bacterial Agents; Candidiasis; Case-Control Studies; Catheterization, Central Venous; Child; Child, Preschool; Female; Fungemia; Humans; Incidence; Infant; Intensive Care Units, Pediatric; Male; Neoplasms; Odds Ratio; Risk Factors; Vancomycin | 2010 |
Clinical factors affecting the efficacy of vancomycin in methicillin-resistant Staphylococcus aureus pneumonia.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Humans; Logistic Models; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Multivariate Analysis; Neoplasms; Parenteral Nutrition; Pneumonia, Staphylococcal; Retrospective Studies; Risk Factors; Severity of Illness Index; Survival Rate; Treatment Outcome; Vancomycin | 2010 |
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study.
Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans | 2010 |
Intestinal colonisation and blood stream infections due to vancomycin-resistant enterococci (VRE) and extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBLE) in patients with haematological and oncological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cohort Studies; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Gastrointestinal Tract; Germany; Humans; Logistic Models; Male; Middle Aged; Neoplasms; Prospective Studies; Risk Factors; Vancomycin; Vancomycin Resistance; Young Adult | 2012 |
Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center.
Topics: Anti-Bacterial Agents; Bacteremia; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Neoplasms; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2012 |
Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Child, Preschool; Drug Resistance, Bacterial; Enterococcus; Female; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Infant; Infection Control; Male; Neoplasms; Stem Cell Transplantation; Time Factors; Transplantation, Homologous; Treatment Outcome; Vancomycin; Vancomycin Resistance | 2004 |
Withholding initial vancomycin in febrile neutropenia despite implanted catheters.
Topics: Adolescent; Amphotericin B; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Child; Child, Preschool; Drug Resistance, Bacterial; Fever; Humans; Infant; Meropenem; Neoplasms; Neutropenia; Prospective Studies; Thienamycins; Vancomycin | 2004 |
Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters.
Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Vancomycin | 2005 |
Vancomycin tolerance, a potential mechanism for refractory gram-positive bacteremia observational study in patients with cancer.
Topics: Adult; Bacteremia; Female; Humans; Male; Middle Aged; Neoplasms; Staphylococcal Infections; Streptococcal Infections; Treatment Failure; Vancomycin; Vancomycin Resistance | 2006 |
Microorganisms mistaken as vancomycin-resistant Staphylococcus aureus at a cancer hospital in Lahore, Pakistan: their true identity revealed.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cross Infection; Female; Humans; Male; Middle Aged; Neoplasms; Pakistan; Serum Bactericidal Test; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2006 |
Relationship of colonization with vancomycin-resistant enterococci and risk of systemic infection in patients with cancer.
Topics: Anti-Bacterial Agents; Enterococcus; Gram-Positive Bacterial Infections; Humans; Neoplasms; Vancomycin; Vancomycin Resistance | 2006 |
Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Enterococcus; Feces; Gram-Positive Bacterial Infections; Humans; Leukemia; Lymphoma; Neoplasms; Predictive Value of Tests; Retrospective Studies; Statistics as Topic; Vancomycin; Vancomycin Resistance | 2006 |
Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patients.
Topics: Bacterial Infections; Drug Combinations; Fever; Humans; Leukocyte Count; Neoplasms; Neutrophils; Piperacillin; Sepsis; Vancomycin | 1984 |
[Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors].
Topics: Adolescent; Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Sulbactam; Vancomycin | 1994 |
Morbidity using subcutaneous ports and efficacy of vancomycin flushing in cancer.
Topics: Adolescent; Age Factors; Bacterial Infections; Catheters, Indwelling; Child; Child, Preschool; Equipment Contamination; Equipment Failure; Female; Humans; Infant; Male; Neoplasms; Risk Factors; Sepsis; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1995 |
A prospective study of vancomycin pharmacokinetics and dosage requirements in pediatric cancer patients.
Topics: Adolescent; Bayes Theorem; Child; Child, Preschool; Humans; Infant; Neoplasms; Prospective Studies; Vancomycin | 1994 |
Vancomycin versus teicoplanin for the treatment of gram-positive bacteremia in patients with cancer.
Topics: Bacteremia; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Neoplasms; Teicoplanin; Vancomycin | 1994 |
Duration of intravenous antibiotics for patients with neutropenic fever.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ceftazidime; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Length of Stay; Leukocyte Count; Male; Middle Aged; Neoplasms; Neutropenia; Neutrophils; Tobramycin; Vancomycin | 1994 |
[Clinical experience with totally implantable venous access systems in pediatric hematology and oncology].
Topics: Adolescent; Catheters, Indwelling; Child; Child, Preschool; Equipment Failure; Hematologic Diseases; Heparin; Humans; Infant; Infections; Neoplasms; Retrospective Studies; Thrombosis; Vancomycin | 1993 |
Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Cancer Care Facilities; Case-Control Studies; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Intensive Care Units; Length of Stay; Male; Matched-Pair Analysis; Methicillin Resistance; Middle Aged; Neoplasms; Neutropenia; Prognosis; Referral and Consultation; Staphylococcal Infections; Staphylococcus aureus; Survival Analysis; Survival Rate; Vancomycin | 1993 |
Influence of malignancy on the pharmacokinetics of vancomycin in infants and children.
Topics: Anti-Bacterial Agents; Bayes Theorem; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infant; Injections, Intravenous; Male; Models, Biological; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1995 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Cross Infection; DNA Fingerprinting; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Middle Aged; Neoplasms; New York; Oncology Service, Hospital; Patient Isolation; Prevalence; Urinary Tract Infections; Vancomycin | 1995 |
Oral care with vancomycin paste for alpha-hemolytic streptococcal sepsis.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacteremia; Child; Drug Resistance, Microbial; Humans; Incidence; Neoplasms; Oral Hygiene; Staphylococcus aureus; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1996 |
Oral care with vancomycin paste for alpha-hemolytic streptococcal sepsis.
Topics: Administration, Topical; Anti-Bacterial Agents; Bacteremia; Child; Humans; Neoplasms; Risk Assessment; Streptococcal Infections; Streptococcus pyogenes; Vancomycin | 1996 |
Nosocomial bacteremia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Bacteremia; Catheterization, Central Venous; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1996 |
Monitoring vancomycin serum concentrations in cancer patients undergoing cytotoxic chemotherapy.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Drug Therapy, Combination; Humans; Infusions, Intravenous; Monitoring, Physiologic; Neoplasms; Neutropenia; Prognosis; Vancomycin | 1996 |
Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Ciprofloxacin; Cyclophosphamide; Estrogens; Female; Genetic Diseases, Inborn; Graft vs Host Disease; Hepatic Veno-Occlusive Disease; Humans; Immunosuppressive Agents; Incidence; Life Tables; Liver Diseases; Liver Function Tests; Male; Methotrexate; Middle Aged; Multiple Organ Failure; Multivariate Analysis; Neoplasms; Progestins; Retrospective Studies; Risk Factors; Transplantation Conditioning; Vancomycin | 1996 |
In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients.
Topics: Anti-Bacterial Agents; Depsipeptides; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Neoplasms; Peptides, Cyclic; Teicoplanin; Vancomycin | 1996 |
Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection.
Topics: Anti-Bacterial Agents; Carrier State; Child; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Feces; Female; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Oncology Service, Hospital; Risk Factors; Vancomycin | 1996 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Do low vancomycine serum levels predict failures of vancomycine therapy in neutropenic cancer patients?
Topics: Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Neoplasms; Neutropenia; Retrospective Studies; Treatment Failure; Vancomycin | 1996 |
Viridans streptococcal bacteraemia due to penicillin-resistant and penicillin-sensitive streptococci: analysis of risk factors and outcome in 60 patients from a single cancer centre before and after penicillin is used for prophylaxis.
Topics: Acute Disease; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Drug Therapy, Combination; Humans; Incidence; Leukemia; Neoplasms; Ofloxacin; Penicillin Resistance; Penicillin V; Penicillins; Retrospective Studies; Risk Factors; Streptococcal Infections; Treatment Outcome; Vancomycin | 1997 |
[Clinical pilot study on repeated use of heparin, vancomycin, colimycine locked flush solution for central intravenous implanted catheter in oncology].
Topics: Anti-Bacterial Agents; Catheterization, Central Venous; Catheters, Indwelling; Colistin; Drug Combinations; Female; Fibrinolytic Agents; Gram-Negative Bacterial Infections; Heparin; Humans; Male; Middle Aged; Neoplasms; Pilot Projects; Vancomycin | 1997 |
Natural history of colonization with vancomycin-resistant Enterococcus faecium.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enteritis; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Vancomycin | 1997 |
Vancomycin-resistant enterococcus.
Topics: Anti-Bacterial Agents; Cross Infection; Drug Resistance, Microbial; Enterococcus; Gram-Positive Bacterial Infections; Humans; Neoplasms; Oncology Nursing; Vancomycin | 1997 |
Analysis of the value of empiric vancomycin administration in febrile neutropenia occurring after autologous peripheral blood stem cell transplants.
Topics: Adult; Aged; Anti-Bacterial Agents; Antineoplastic Agents; Cost-Benefit Analysis; Drug Resistance, Microbial; Female; Fever; Gram-Positive Bacterial Infections; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies; Transplantation, Autologous; Treatment Outcome; Vancomycin | 1998 |
Mississippi mud in the 1990s: risks and outcomes of vancomycin-associated toxicity in general oncology practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Drug Resistance, Microbial; Female; Hearing Disorders; Humans; Immunocompromised Host; Kidney; Male; Middle Aged; Neoplasms; Phlebitis; Prospective Studies; Regression Analysis; Vancomycin | 1998 |
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas | 1998 |
[Bacteremia due to vancomycin-resistant enterococci in neutropenic cancer patients].
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; Drug Resistance, Microbial; Drug Therapy, Combination; Enterococcus faecium; Female; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Vancomycin | 1998 |
Role of transposon Tn5482 in the epidemiology of vancomycin-resistant Enterococcus faecium in the pediatric oncology unit of a New York City Hospital.
Topics: Anti-Bacterial Agents; Child; Conjugation, Genetic; Cross Infection; DNA Fragmentation; DNA Probes; DNA Transposable Elements; Drug Resistance, Microbial; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Gram-Positive Bacterial Infections; Hospital Units; Hospitals, Urban; Humans; Medical Oncology; Neoplasms; New York City; Nucleic Acid Hybridization; Pediatrics; Vancomycin | 1999 |
Effects of hepatic function on vancomycin pharmacokinetics in patients with cancer.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Female; Humans; Linear Models; Liver; Liver Failure; Male; Middle Aged; Models, Biological; Neoplasms; Vancomycin | 2000 |
Medicare may not reimburse for certain AIDS and cancer drugs.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin | 1995 |
Risk factors for vancomycin-resistant Enterococcus (VRE) infection in colonized patients with cancer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Case-Control Studies; Child; Child, Preschool; Cross Infection; Enterococcus; Female; Humans; Infant; Male; Middle Aged; Neoplasms; Risk Factors; Texas; Vancomycin; Vancomycin Resistance | 2002 |
Corynebacterium sepsis in oncology patients. Predisposing factors, diagnosis, and treatment.
Topics: Adult; Aged; Antineoplastic Agents; Corynebacterium Infections; Disease Susceptibility; Female; Humans; Immunity; Male; Middle Aged; Neoplasms; Sepsis; Vancomycin | 1977 |
Nephrotoxicity of aminoglycosides, polypeptides and cephalosporins in cancer patients.
Topics: Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Cephalosporins; Drug Therapy, Combination; Humans; Kidney; Neoplasms; Retrospective Studies; Vancomycin | 1991 |
In vitro activity of LY264826, a new glycopeptide antibiotic, against gram-positive bacteria isolated from patients with cancer.
Topics: Anti-Bacterial Agents; Bacterial Infections; Culture Media; Gram-Positive Bacteria; Humans; Hydrogen-Ion Concentration; Microbial Sensitivity Tests; Neoplasms; Oxacillin; Teicoplanin; Vancomycin | 1990 |
Combination and single-agent empirical antibacterial therapy for febrile cancer patients with neutropenia and mucositis.
Topics: Agranulocytosis; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Humans; Infections; Mouth Mucosa; Neoplasms; Neutropenia; Stomatitis; Vancomycin | 1990 |
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients.
Topics: Amikacin; Anti-Bacterial Agents; Cephalothin; Gram-Positive Bacteria; Humans; Neoplasms; Spectinomycin; Staphylococcus; Streptococcus; Vancomycin | 1989 |
Spectrum and outcome of microbiologically documented listeria monocytogenes infections in cancer patients.
Topics: Adult; Aged; Ampicillin; Female; Humans; Immunosuppressive Agents; Listeriosis; Male; Meningitis, Listeria; Middle Aged; Neoplasms; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1989 |
Antibiotics for the treatment of febrile children with neutropenia and cancer.
Topics: Agranulocytosis; Bacterial Infections; Child; Drug Therapy, Combination; Fever; Humans; Neoplasms; Neutropenia; Vancomycin | 1989 |
Gram-positive infections and the use of vancomycin in 550 episodes of fever and neutropenia.
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Drug Therapy, Combination; Fever; Gram-Positive Bacteria; Humans; Neoplasms; Neutropenia; Random Allocation; Retrospective Studies; Sepsis; Staphylococcus; Streptococcus; Vancomycin | 1988 |
Relationship of serum antibiotic concentrations to nephrotoxicity in cancer patients receiving concurrent aminoglycoside and vancomycin therapy.
Topics: Aminoglycosides; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Kidney; Male; Middle Aged; Neoplasms; Staphylococcal Infections; Vancomycin | 1987 |
In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer.
Topics: Acetylcysteine; Bacterial Infections; Disaccharides; Glycopeptides; Gram-Positive Bacteria; Neoplasms; Vancomycin | 1987 |
Intravenous catheter-associated Staphylococcus epidermidis bacteremia in hematology/oncology patients.
Topics: Catheterization, Central Venous; Hematologic Diseases; Humans; Microbial Sensitivity Tests; Neoplasms; Staphylococcal Infections; Staphylococcus epidermidis; Vancomycin | 1987 |